TL-895 | Interleukin Related interleukin-related.com

Product Name :
TL-895

Search keywords :
TL-895

drugId :
null

Target Vo:
Neurotrophic tyrosine kinase receptor

Target Vo Short Name :
NTRK

Moa_Name:
Neurotrophic tyrosine kinase receptor inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Telios Pharmaceuticals

Active Company_Name :
Kartos Therapeutics Inc

Active Indication_Name:
Primary Myelofibrosis

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
beta III Tubulin Rabbit mAb manufacturer
Atacicept In Vitro
Phospho-CREB (Ser133) Antibody (YA209): Phospho-CREB (Ser133) Antibody (YA209) is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to Phospho-CREB (Ser133). It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts